Tag: DBT

The facility exemplifies how technological advancements in bioplastics can lead to economic growth

The Cover Story focuses on the impact of BIOE3 policy. Read Special Interview of Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research. Expert Insights by Dr Prabhu Vinayagam, Medical Advisor, Orchid AMS and Shashank Avadhani, CEO and Co-founder, Alyve Health. Special stories on MPox virus, AMR and AgriTech.

In an exclusive rapid-fire interview on the sidelines of Global Bio India 2024 in New Delhi, Davender Kumar Bhati, Co-Founder & Director, Invigorate Biotechnologies shared insights on his company’s key R&D focus areas, startup ecosystem, government policies and much more.

The Bio-RIDE scheme, with a budget of Rs. 9,197 crore, aims to promote bio-entrepreneurship, and advance research, through innovations and sustainable practices

Arun Prakash Chief Executive Officer Genetix Biotech Asia recently on the sidelines of Global Bio India 2024 in New Delhi shared his insights on his company focus on global collaborations, industry's key growth drivers, India's US$ 300 billion bioeconomy target by 2030 and much more.

The roundtable convened 25+ leading biotech experts, policymakers, industry leaders, domestic and global investors to explore emerging trends and investment opportunities

Aligned to the recently approved BioE3 policy, the partnership will fast-track innovation and tech driven support in the bio-medical field

At the valedictory session, announcement of Letters of Intent with BIRAC were exchanged by the Children's Investment Fund Foundation and IPE Global for co-funding partnerships

This new policy signals a pivotal moment in the country's sustainable development strategy

Being organized by the BIRAC and DBT, the largest biotech event in the country will be held at Hall No. 5, Pragati Maidan